Integrating in situ vaccination with checkpoint blockade therapy: a novel approach to enhance anti-tumour immunity in colorectal cancer

Colorectal cancer (CRC) remains a challenging disease due to its high diversity and complex immune escape mechanisms. The anticipated incidence of colorectal cancer is expected to reach 3,200,000 new cases per year, indicating a 63% increase, with an estimated 1,600,000 deaths occurring annually, wh...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Tolulope A. Owolabi, Samson A. Adeyemi, Lindokuhle M. Ngema, Clement Penny, Yahya E. Choonara
Format:	Artigo
Sprog:	Inglês
Udgivet:	ELS Publishing (ELSP) 2025-05-01
Serier:	Biofunctional Materials
Fag:	colorectal cancer immunotherapy immune checkpoint inhibitors in situ vaccination combination therapy therapeutic peptides pd-1/pd-l1 inhibitors dendritic cells
Online adgang:	https://elsp-homepage.oss-cn-hongkong.aliyuncs.compaper/journal/open/BM/2025/bm20250007.pdf
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!